N-(2-amino-2-oxoethyl)-[2-[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]oxy-N-[hydroxy-(12-methyltridecylamino)oxyphosphoryl]phosphonamidic acid

Term ID

CHEBI:204616

Synonyms

N-(2-amino-2-oxoethyl)-[2-[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]oxy-N-[hydroxy-(12-methyltridecylamino)oxyphosphoryl]phosphonamidic acid

Definition

References

Chemspider:78444990

Ontology

ChEBI ( EBI )

Relationships

is a type of: pyrimidine nucleoside

pyrimidine nucleoside Show first 5 Terms

Phenotype

Phenotype resulting from N-(2-amino-2-oxoethyl)-[2-[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]oxy-N-[hydroxy-(12-methyltridecylamino)oxyphosphoryl]phosphonamidic acid

Phenotype where environments contain N-(2-amino-2-oxoethyl)-[2-[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]oxy-N-[hydroxy-(12-methyltridecylamino)oxyphosphoryl]phosphonamidic acid

Phenotype modified by environments containing N-(2-amino-2-oxoethyl)-[2-[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]oxy-N-[hydroxy-(12-methyltridecylamino)oxyphosphoryl]phosphonamidic acid

Human Disease Model